Trial Profile
Lucentis in the Treatment of Retinoblastoma - A Phase II, Single Center, Randomized Study to Evaluate the Efficacy of Ranibizumab in Subjects With Retinoblastoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary) ; Carboplatin; Etoposide; Vincristine
- Indications Retinoblastoma
- Focus Therapeutic Use
- 24 Jul 2013 New trial record